Analytical validation of a melanoma diagnostic gene signature using formalin-fixed paraffin-embedded melanocytic lesions
Abstract
Aim: These studies were to validate the analytical performance of a gene expression signature that differentiates melanoma and nevi, using RNA expression from 14 signature genes and nine normalization genes that generates a melanoma diagnostic score (MDS). Materials & Methods: Formalin-fixed paraffin-embedded melanocytic lesions were evaluated in these studies. Results: The overall SD of the assay was determined to be 0.69 MDS units. Individual amplicons within the signature had an average amplification efficiency of 92% and a SD less than 0.5 CT. The MDS was reproducible across a 2000-fold dilution range of input RNA. Melanin, an inhibitor of PCR, does not interfere with the signature. Conclusion: These studies indicate this signature is robust and reproducible and is analytically validated on formalin-fixed paraffin-embedded melanocytic lesions.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 American Cancer Society. What are the key statistics about melanoma skin cancer? www.cancer.org
- 2 Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am. J. Surg. Pathol. 34(3), 314–326 (2010).
- 3 . Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum. Pathol. 27(6), 528–531 (1996).• Along with [5], a high-value study of the discordance of histopathologic review of melanocytic lesion.
- 4 Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. Arch. Dermatol. 138(5), 617–621 (2002).
- 5 . Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J. Am. Acad. Dermatol. 62(5), 751–756 (2010).• Along with [3], a high-value study of the discordance of histopathologic review of melanocytic lesion.
- 6 Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J. Cutan. Pathol. doi:10.1111/cup.12475 (2015) (Epub ahead of print).•• Provides full details on the development of the gene signature and its validation for clinical use.
- 7 . An improved method for RNA isolation and removal of melanin contamination from melanoma tissue: implications for tumor antigen detection and amplification. J. Immunol. Methods 313(1–2), 119–128 (2006).• Demonstrates the potential interference that melanin might cause within PCR reactions.
- 8 . Melanin binds reversibly to thermostable DNA polymerase and inhibits its activity. Biochem. Biophys. Res. Commun. 271(3), 726–730 (2000).
- 9 Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin. Chem. 53(6), 1084–1091 (2007).
- 10 Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies. BMC Genomics 14, 690 (2013).
- 11 Analytical validation of the PAM50-based prosigna breast cancer prognostic gene signature assay and counter analysis system using formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer 14, 177 (2014).
- 12 . Preparation and properties of the melanin from Lachnum singerianum. Int. J. Bas. Appl. Sci. 11(3), 51–57 (2011).
- 13 Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol. 12(3), 245–255 (2011).
- 14 Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br. J. Cancer 106(6), 1095–1099 (2012).
- 15 Improved RNA quality and TaqMan pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials. BMC Biotechnol. 8, 10 (2008).
- 16 . Microchamber array based DNA quantification and specific sequence detection from a single copy via PCR in nanoliter volumes. Biosens. Bioelectron. 20(8), 1482–1490 (2005).